Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00375011 · ClinicalTrials.gov registry record

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

A clinical trial, sponsored by Meridian Bioscience.

Terminated
Registry status
200
Enrollment target

NCT00375011: Clinical Trial study, sponsored by Meridian Bioscience.

NCT00375011 is a clinical trial that was terminated before completion, run by Meridian Bioscience. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00375011 was terminated before completion, sponsored by Meridian Bioscience.

TERMINATED
Registry status
200 participants
Enrollment target

Study Summary

The three objectives of this trial are: 1. To demonstrate that a decline in hepatic metabolic function as measured by BreathID will correlate with changes in CTP and MELD scores in patients with cirrhosis. 2. To determine the critical value of hepatic metabolic function as measured by BreathID will predict which patients are at risk to develop complications of cirrhosis. 3. To determine the critical value of hepatic metabolic function as measured by BreathID will predict which patients are at risk for liver related mortality. The hypothesis is that the BreathID breath test will correlate to CTP and MELD scores, and that thresholds can be established that will help predict risk of complications of cirrhosis and mortality.

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2008-09
Est. Completion 2011-10
Meridian Bioscience

19 total trials

Why NCT00375011 stopped before completion

NCT00375011 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00375011 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00375011 about?

NCT00375011 is a clinical study titled "Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics". The three objectives of this trial are: 1. To demonstrate that a decline in hepatic metabolic function as measured by BreathID will correlate with changes in CTP and MELD scores in patients with cirrhosis. 2. To determine the critical value of hepatic metabolic function as measured by BreathID will...

What is the current status of trial NCT00375011?

This trial is currently terminated. The enrollment target is 200 participants. The study started on 2008-09. Estimated completion is 2011-10.

Who is sponsoring clinical trial NCT00375011?

This trial is sponsored by Meridian Bioscience, which has 19 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00375011, the US trial registry maintained by the National Library of Medicine. NCT00375011 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.